ALKB homologs (ALKBH) homologs can regulate the physiological and pathological processes of cardiovascular diseases (CVDs), which have great potential in the development of CVD drugs and are expected to become a potential target for the treatment of CVD (Xiao et al., 2020). This evidence concerns the gene ALKBH1 and cardiovascular disorder.